Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Secretion of the Shiga toxin B subunit (Stx1B) via an autotransporter protein optimizes the protective immune response to the antigen expressed in an attenuated E. coli (rEPEC E22Δler) vaccine strain.

Byrd W, Ruiz-Perez F, Setty P, Zhu C, Boedeker EC.

Vet Microbiol. 2017 Nov;211:180-188. doi: 10.1016/j.vetmic.2017.10.006. Epub 2017 Oct 10.

PMID:
29102116
2.

Development of live attenuated bacterial vaccines targeting Escherichia coli heat-labile and heat-stable enterotoxins.

Zhu C, Setty P, Boedeker EC.

Vet Microbiol. 2017 Apr;202:72-78. doi: 10.1016/j.vetmic.2017.04.010. Epub 2017 Apr 14.

PMID:
28527491
3.

Correction: Identification of Candidate Adherent-Invasive E. coli Signature Transcripts by Genomic/Transcriptomic Analysis.

Zhang Y, Rowehl L, Krumsiek JM, Orner EP, Shaikh N, Tarr PI, Sodergren E, Weinstock GM, Boedeker EC, Xiong X, Parkinson J, Frank DN, Li E, Gathungu G.

PLoS One. 2015 Jul 28;10(7):e0134759. doi: 10.1371/journal.pone.0134759. eCollection 2015. No abstract available.

4.

Identification of Candidate Adherent-Invasive E. coli Signature Transcripts by Genomic/Transcriptomic Analysis.

Zhang Y, Rowehl L, Krumsiek JM, Orner EP, Shaikh N, Tarr PI, Sodergren E, Weinstock GM, Boedeker EC, Xiong X, Parkinson J, Frank DN, Li E, Gathungu G.

PLoS One. 2015 Jun 30;10(6):e0130902. doi: 10.1371/journal.pone.0130902. eCollection 2015. Erratum in: PLoS One. 2015;10(7):e0134759.

5.

The secreted effector protein EspZ is essential for virulence of rabbit enteropathogenic Escherichia coli.

Wilbur JS, Byrd W, Ramamurthy S, Ledvina HE, Khirfan K, Riggs MW, Boedeker EC, Vedantam G, Viswanathan VK.

Infect Immun. 2015 Mar;83(3):1139-49. doi: 10.1128/IAI.02876-14. Epub 2015 Jan 5.

6.

Serine protease EspP from enterohemorrhagic Escherichia coli is sufficient to induce shiga toxin macropinocytosis in intestinal epithelium.

In J, Lukyanenko V, Foulke-Abel J, Hubbard AL, Delannoy M, Hansen AM, Kaper JB, Boisen N, Nataro JP, Zhu C, Boedeker EC, Girón JA, Kovbasnjuk O.

PLoS One. 2013 Jul 18;8(7):e69196. doi: 10.1371/journal.pone.0069196. Print 2013.

7.

Role of host xanthine oxidase in infection due to enteropathogenic and Shiga-toxigenic Escherichia coli.

Crane JK, Naeher TM, Broome JE, Boedeker EC.

Infect Immun. 2013 Apr;81(4):1129-39. doi: 10.1128/IAI.01124-12. Epub 2013 Jan 22.

9.

A directed intimin insertion mutant of a rabbit enteropathogenic Escherichia coli (REPEC) is attenuated, immunogenic and elicits serogroup specific protection.

Ahmed S, Byrd W, Kumar S, Boedeker EC.

Vet Immunol Immunopathol. 2013 Mar 15;152(1-2):146-55. doi: 10.1016/j.vetimm.2012.09.035. Epub 2012 Sep 27.

PMID:
23084628
10.

Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition.

Li E, Hamm CM, Gulati AS, Sartor RB, Chen H, Wu X, Zhang T, Rohlf FJ, Zhu W, Gu C, Robertson CE, Pace NR, Boedeker EC, Harpaz N, Yuan J, Weinstock GM, Sodergren E, Frank DN.

PLoS One. 2012;7(6):e26284. doi: 10.1371/journal.pone.0026284. Epub 2012 Jun 13.

11.

Virulence inhibition by zinc in shiga-toxigenic Escherichia coli.

Crane JK, Byrd IW, Boedeker EC.

Infect Immun. 2011 Apr;79(4):1696-705. doi: 10.1128/IAI.01099-10. Epub 2011 Jan 18.

12.

Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases.

Frank DN, Robertson CE, Hamm CM, Kpadeh Z, Zhang T, Chen H, Zhu W, Sartor RB, Boedeker EC, Harpaz N, Pace NR, Li E.

Inflamm Bowel Dis. 2011 Jan;17(1):179-84. doi: 10.1002/ibd.21339. Epub 2010 Sep 13.

13.

Development of a live oral attaching and effacing Escherichia coli vaccine candidate using Vibrio cholerae CVD 103-HgR as antigen vector.

Keller R, Hilton TD, Rios H, Boedeker EC, Kaper JB.

Microb Pathog. 2010 Jan;48(1):1-8. doi: 10.1016/j.micpath.2009.10.005. Epub 2009 Oct 28.

14.

Shiga toxin 1 interaction with enterocytes causes apical protein mistargeting through the depletion of intracellular galectin-3.

Laiko M, Murtazina R, Malyukova I, Zhu C, Boedeker EC, Gutsal O, O'Malley R, Cole RN, Tarr PI, Murray KF, Kane A, Donowitz M, Kovbasnjuk O.

Exp Cell Res. 2010 Feb 15;316(4):657-66. doi: 10.1016/j.yexcr.2009.09.002. Epub 2009 Sep 8.

15.

Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections.

Serna A 4th, Boedeker EC.

Curr Opin Gastroenterol. 2008 Jan;24(1):38-47. Review.

PMID:
18043231
16.

Gastrointestinal infections, an overview: from pathogens to metagenomes.

Boedeker EC.

Curr Opin Gastroenterol. 2008 Jan;24(1):1-3. No abstract available.

PMID:
18043224
17.

Protection against Shiga toxin-producing Escherichia coli infection by transcutaneous immunization with Shiga toxin subunit B.

Zhu C, Yu J, Yang Z, Davis K, Rios H, Wang B, Glenn G, Boedeker EC.

Clin Vaccine Immunol. 2008 Feb;15(2):359-66. Epub 2007 Nov 14.

18.

Effect of zinc in enteropathogenic Escherichia coli infection.

Crane JK, Naeher TM, Shulgina I, Zhu C, Boedeker EC.

Infect Immun. 2007 Dec;75(12):5974-84. Epub 2007 Sep 17.

19.

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.

Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR.

Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13780-5. Epub 2007 Aug 15.

20.

The possible influence of LuxS in the in vivo virulence of rabbit enteropathogenic Escherichia coli.

Zhu C, Feng S, Sperandio V, Yang Z, Thate TE, Kaper JB, Boedeker EC.

Vet Microbiol. 2007 Dec 15;125(3-4):313-22. Epub 2007 Jun 15.

21.

LEE-encoded regulator (Ler) mutants elicit serotype-specific protection, but not cross protection, against attaching and effacing E. coli strains.

Zhu C, Feng S, Yang Z, Davis K, Rios H, Kaper JB, Boedeker EC.

Vaccine. 2007 Feb 26;25(10):1884-92. Epub 2006 Oct 27.

PMID:
17234305
22.

Gut microbes, the innate immune system and inflammatory bowel disease: location, location, location.

Boedeker EC.

Curr Opin Gastroenterol. 2007 Jan;23(1):1-3. No abstract available.

PMID:
17133076
23.

Helicobacter pylori infection: treatment.

Belhoussine-Idrissi L, Boedeker EC.

Curr Opin Gastroenterol. 2002 Jan;18(1):26-33.

PMID:
17031226
24.

Gastrointestinal infections.

Boedeker EC.

Curr Opin Gastroenterol. 2000 Jan;16(1):1-3. No abstract available.

PMID:
17024008
25.

Current status of enteric vaccines.

Boedeker EC.

Curr Opin Gastroenterol. 1999 Jan;15(1):39-42. No abstract available.

PMID:
17023916
26.

The QseC sensor kinase: a bacterial adrenergic receptor.

Clarke MB, Hughes DT, Zhu C, Boedeker EC, Sperandio V.

Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10420-10425. doi: 10.1073/pnas.0604343103. Epub 2006 Jun 27.

27.
29.

Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli.

Zhu C, Ruiz-Perez F, Yang Z, Mao Y, Hackethal VL, Greco KM, Choy W, Davis K, Butterton JR, Boedeker EC.

Vaccine. 2006 May 1;24(18):3821-31. Epub 2005 Jul 25.

PMID:
16098637
30.

Gastrointestinal infections: an overview.

Boedeker EC.

Curr Opin Gastroenterol. 2004 Jan;20(1):1-2. No abstract available.

PMID:
15703611
31.

Foodborne enteric infections.

Mao Y, Zhu C, Boedeker EC.

Curr Opin Gastroenterol. 2003 Jan;19(1):11-22.

PMID:
15699888
32.

Gastrointestinal infections.

Boedeker EC.

Curr Opin Gastroenterol. 2003 Jan;19(1):1-3. No abstract available.

PMID:
15699886
33.

Vaccines for enterotoxigenic Escherichia coli: current status.

Boedeker EC.

Curr Opin Gastroenterol. 2005 Jan;21(1):15-9. Review.

PMID:
15687879
34.

Enteric infections.

Boedeker EC.

Curr Opin Gastroenterol. 2005 Jan;21(1):1-3. No abstract available.

PMID:
15687876
35.

Use of a continuous-flow anaerobic culture to characterize enteric virulence gene expression.

Ruiz-Perez F, Sheikh J, Davis S, Boedeker EC, Nataro JP.

Infect Immun. 2004 Jul;72(7):3793-802.

36.

Enteropathogenic Escherichia coli strain RDEC-1 produces a novel electrogenic factor active on rabbit ileum in vitro.

Raimondi F, Kaper JB, Boedeker EC, Wolf MK, Guandalini S, Fasano A.

J Pediatr Gastroenterol Nutr. 2001 Feb;32(2):122-6.

PMID:
11321378
37.

Complete nucleotide sequence and analysis of the locus of enterocyte Effacement from rabbit diarrheagenic Escherichia coli RDEC-1.

Zhu C, Agin TS, Elliott SJ, Johnson LA, Thate TE, Kaper JB, Boedeker EC.

Infect Immun. 2001 Apr;69(4):2107-15.

38.

Crohn's mucosa harbors adherent-invasive E. coli.

Boedeker EC.

Inflamm Bowel Dis. 2000 May;6(2):155. No abstract available.

PMID:
10833079
39.

A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains.

Karaolis DK, Johnson JA, Bailey CC, Boedeker EC, Kaper JB, Reeves PR.

Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3134-9.

40.

The CS6 colonization factor of human enterotoxigenic Escherichia coli contains two heterologous major subunits.

Wolf MK, de Haan LA, Cassels FJ, Willshaw GA, Warren R, Boedeker EC, Gaastra W.

FEMS Microbiol Lett. 1997 Mar 1;148(1):35-42.

41.

Cloning of the RDEC-1 locus of enterocyte effacement (LEE) and functional analysis of the phenotype on HEp-2 cells.

Karaolis DK, McDaniel TK, Kaper JB, Boedeker EC.

Adv Exp Med Biol. 1997;412:241-5.

PMID:
9192020
42.

Enterohemorrhagic Escherichia coli: a family of emerging pathogens.

Noël JM, Boedeker EC.

Dig Dis. 1997 Jan-Apr;15(1-2):67-91. Review.

PMID:
9101130
44.

Mucosal immune responses to intestinal bacterial pathogens.

Bloom PD, Boedeker EC.

Semin Gastrointest Dis. 1996 Jul;7(3):151-66. Review.

PMID:
8817767
45.
46.

Intraduodenal immunization with microencapsulated CFA/II induces a delayed, anti-CFA/II, IgG antibody-secreting spleen cell response.

Sau K, Reid RH, McQueen C, Boedeker EC, Nellore R, Dalal P, Bhagat HR.

Adv Exp Med Biol. 1995;371B:1469-74. No abstract available.

PMID:
7502839
47.

Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres.

Tacket CO, Reid RH, Boedeker EC, Losonsky G, Nataro JP, Bhagat H, Edelman R.

Vaccine. 1994 Nov;12(14):1270-4.

PMID:
7856290
48.

Adherent bacteria: breaching the mucosal barrier?

Boedeker EC.

Gastroenterology. 1994 Jan;106(1):255-7. No abstract available.

PMID:
8276191
49.

Characterization of enterotoxigenic Escherichia coli isolated from U.S. troops deployed to the Middle East.

Wolf MK, Taylor DN, Boedeker EC, Hyams KC, Maneval DR, Levine MM, Tamura K, Wilson RA, Echeverria P.

J Clin Microbiol. 1993 Apr;31(4):851-6.

50.

Preclinical evaluation of microencapsulated CFA/II oral vaccine against enterotoxigenic E. coli.

Reid RH, Boedeker EC, McQueen CE, Davis D, Tseng LY, Kodak J, Sau K, Wilhelmsen CL, Nellore R, Dalal P, et al.

Vaccine. 1993;11(2):159-67.

PMID:
8438614

Supplemental Content

Loading ...
Support Center